Multiplan (MPLN) | Financial Analysis & Statements
Multiplan Corporation Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2024Income Metrics
Revenue
232.1M
Gross Profit
175.0M
75.39%
Operating Income
13.1M
5.66%
Net Income
-138.0M
-59.43%
Balance Sheet Metrics
Total Assets
5.2B
Total Liabilities
5.1B
Shareholders Equity
84.0M
Debt to Equity
60.30
Cash Flow Metrics
Operating Cash Flow
-67.3M
Free Cash Flow
-63.8M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2024
Annual Income Flow
2024
Multiplan Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 930.6M | 961.5M | 1.1B | 1.1B | 937.8M |
| Cost of Goods Sold | 239.4M | 235.5M | 204.1M | 175.3M | 318.7M |
| Gross Profit | 691.2M | 726.1M | 875.6M | 942.3M | 619.1M |
| Gross Margin % | 74.3% | 75.5% | 81.1% | 84.3% | 66.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 160.2M | 136.0M | 132.1M | 151.1M | 355.6M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 160.2M | 136.0M | 132.1M | 151.1M | 355.6M |
| Operating Income | 98.9M | 170.0M | 334.2M | 386.1M | -131.8M |
| Operating Margin % | 10.6% | 17.7% | 31.0% | 34.5% | -14.1% |
| Non-Operating Items | |||||
| Interest Income | 3.1M | 8.2M | 3.5M | 30.0K | 288.0K |
| Interest Expense | 326.4M | 333.2M | 303.4M | 267.5M | 335.6M |
| Other Non-Operating Income | -1.5B | 47.9M | -595.0M | 16.8M | -79.7M |
| Pre-tax Income | -1.8B | -107.1M | -560.7M | 135.5M | -546.9M |
| Income Tax | -124.9M | -15.4M | 12.2M | 33.4M | -26.3M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 24.6% | 0.0% |
| Net Income | -1.6B | -91.7M | -572.9M | 102.1M | -520.6M |
| Net Margin % | -176.9% | -9.5% | -53.1% | 9.1% | -55.5% |
| Key Metrics | |||||
| EBITDA | 538.5M | 604.1M | 753.3M | 798.2M | 272.1M |
| EPS (Basic) | - | $-5.60 | $-36.00 | $6.40 | $-44.80 |
| EPS (Diluted) | - | $-5.60 | $-36.00 | $6.40 | $-44.80 |
| Basic Shares Outstanding | - | 16128366 | 15973142 | 16275164 | 11769629 |
| Diluted Shares Outstanding | - | 16128366 | 15973142 | 16275164 | 11769629 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Multiplan Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 16.8M | 71.5M | 334.0M | 185.3M | 126.8M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 89.8M | 76.6M | 78.9M | 99.9M | 63.2M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 7.0M | 10.7M | 3.7M | 999.0K | 1.2M |
| Total Current Assets | 175.5M | 193.6M | 446.7M | 319.3M | 208.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 16.1M | 19.7M | 24.2M | 30.1M | 31.3M |
| Goodwill | 7.0B | 10.3B | 10.4B | 12.0B | 12.1B |
| Intangible Assets | 2.2B | 2.6B | 2.9B | 3.3B | 3.6B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 37.1M | 21.8M | 21.9M | 9.7M | 14.2M |
| Total Non-Current Assets | 5.0B | 6.8B | 6.9B | 7.9B | 8.1B |
| Total Assets | 5.2B | 7.0B | 7.4B | 8.2B | 8.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 86.3M | 19.6M | 13.3M | 13.0M | 15.3M |
| Short-term Debt | 17.6M | 18.0M | 19.6M | 20.1M | 6.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 213.8M | 166.7M | 175.8M | 141.9M | 112.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.5B | 4.5B | 4.8B | 4.9B | 4.6B |
| Deferred Tax Liabilities | 325.8M | 521.7M | 639.5M | 753.8M | 900.6M |
| Other Non-Current Liabilities | 3.6M | 16.8M | 28.0K | 135.0K | - |
| Total Non-Current Liabilities | 4.9B | 5.1B | 5.4B | 5.7B | 5.6B |
| Total Liabilities | 5.1B | 5.3B | 5.6B | 5.9B | 5.7B |
| Equity | |||||
| Common Stock | 2.0K | 67.0K | 67.0K | 67.0K | 66.0K |
| Retained Earnings | -2.1B | -499.3M | -347.8M | 225.1M | 117.0M |
| Treasury Stock | 138.7M | 128.4M | 192.2M | 192.2M | 89.6M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 84.0M | 1.7B | 1.8B | 2.3B | 2.6B |
| Key Metrics | |||||
| Total Debt | 4.5B | 4.6B | 4.8B | 4.9B | 4.6B |
| Working Capital | -38.3M | 26.9M | 270.9M | 177.3M | 96.4M |
Balance Sheet Composition
Multiplan Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -1.6B | -91.7M | -572.9M | 102.1M | -520.6M |
| Depreciation & Amortization | 436.4M | 425.8M | 415.7M | 412.1M | 403.7M |
| Stock-Based Compensation | 26.6M | 18.0M | 16.7M | 18.0M | 406.1M |
| Working Capital Changes | 23.5M | -15.3M | 48.8M | -32.0M | 35.4M |
| Operating Cash Flow | -1.3B | 233.4M | -195.5M | 430.5M | 302.4M |
| Investing Activities | |||||
| Capital Expenditures | -118.1M | -108.9M | -89.7M | -84.6M | -70.8M |
| Acquisitions | 0 | -140.9M | -15.0M | -149.4M | -140.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | 0 | 289.0K | 5.6M | 0 |
| Investing Cash Flow | -118.1M | -249.8M | -104.4M | -228.4M | -210.8M |
| Financing Activities | |||||
| Share Repurchases | -10.4M | -15.2M | 0 | -100.0M | -101.1M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | 0 | 0 | 2.3B | 2.7B |
| Debt Repayment | -28.1M | -165.8M | -113.2M | -2.3B | -467.0M |
| Financing Cash Flow | -42.5M | -181.5M | -115.7M | -114.7M | -61.6M |
| Free Cash Flow | -10.5M | 62.9M | 282.6M | 320.1M | 306.6M |
| Net Change in Cash | -1.5B | -197.8M | -415.7M | 87.4M | 29.9M |
Cash Flow Trend
Multiplan Key Financial Ratios
Valuation Ratios
Forward P/E
-2.66
Price to Sales
0.30
Profitability Ratios
Profit Margin
74.27%
Operating Margin
-155.20%
Return on Equity
-1,958.81%
Return on Assets
-31.95%
Financial Health
Current Ratio
0.82
Debt to Equity
54.05
Per Share Data
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MPLN | 282.6M | - | - | -1,958.81% | 74.27% | 54.05 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Omnicell | 1.7B | 918.75 | 1.34 | 0.17% | 0.17% | 16.59 |
| Teladoc Health | 1.0B | - | 0.74 | -13.93% | -7.92% | 75.06 |
| Certara | 969.0M | 105.00 | 0.95 | -0.15% | -0.38% | 28.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.






